Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NOP58 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | TOMM5 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | KRT18 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | REEP5 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | TRABD | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | POLR1D | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | E2F3 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | MFSD7 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
mRNA | CSNK1E | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | IGFBP7 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |